Skip to content
Screener

Other, net at other companies

Danaher logo
DanaherDHR
-$43M-10.3%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
-$600K+25.0%
Novanta logo
NovantaNOVT
-$199K+92.8%
Teledyne Technologies logo
Teledyne TechnologiesTDY
-$5.1M-1,600%
Labcorp Holdings logo
Labcorp HoldingsLH
-$3.4M-3.0%

Other financials

Income statement

See full
Revenue$5.3B+5.8%
Gross profit$2.2B+9.8%
Operating income$739.0M+13.0%
Net income$561.0M+15.4%
EPS (diluted)$1.24+17.0%

Balance sheet

See full
Total debt$10.5B-1.6%
Total equity$11.0B+13.0%
Total assets$37.2B+4.9%

Cash flow

See full
Operating cash flow$168.0M+78.7%
CapEx$100.0M+16.3%
Free cash flow$68.0M+750%

Valuation

See full
Market cap$31.76B-0.6%
P/E16×+1.7×
P/S1.5×-0.1×

Profitability

See full
Gross margin39.5%-2.0pp
Operating margin12.9%-1.0pp
Net margin9.3%-1.9pp
FCF margin7.4%-0.4pp

Returns & leverage

See full
Return on equity19.2%-6.4pp
Debt / equity-0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: GE HealthCare Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:27 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001932393-26-000046
Condensed Consolidated Statements of Cash Flows (Unaudited) / (In millions)For the six months ended June 30 / 2026For the six months ended June 30 / 2025
Repurchase of common stock(300)(100)
Proceeds from stock issued under employee benefit plans1021
Taxes paid related to net share settlement of equity awards(21)(33)
All other financing activities – net(12)(15)
Cash from (used for) financing activities(215)1,075
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash(35)84
Increase (decrease) in cash, cash equivalents, and restricted cash(2,407)873
Cash, cash equivalents, and restricted cash at beginning of year4,5152,893

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is GE HealthCare Technologies's other, net?
GE HealthCare Technologies (GEHC) reported other, net of -$10M in Q2 2026.
How has GE HealthCare Technologies's other, net changed year-over-year?
GE HealthCare Technologies's other, net decreased by 11.1% year-over-year, from -$9M to -$10M.
What is the long-term trend for GE HealthCare Technologies's other, net?
Over 4 years (2021 to 2025), GE HealthCare Technologies's other, net has grown at a 58.0% compound annual growth rate (CAGR), from -$13M to -$81M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about GE HealthCare Technologies's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude